Adaptin Bio (APTN) Other Accumulated Expenses (2022 - 2025)

Adaptin Bio has disclosed Other Accumulated Expenses across 4 years of filings, most recently posting $12576.0 for Q1 2025.

• Quarterly Other Accumulated Expenses fell 65.31% year-over-year to $12576.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $12576.0 (down 65.31% YoY) and the FY2023 annual result came in at $10000.0, down 33.33% from the prior year.
• Other Accumulated Expenses fell to $12576.0 in Q1 2025, from $44750.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $44750.0 in Q3 2024 and bottomed at $10000.0 in Q4 2023.
• The 4-year median for Other Accumulated Expenses is $25625.0 (2022), against an average of $26512.7.
• Year-over-year, Other Accumulated Expenses sank 33.33% in 2023 and sank 65.31% in 2025.
• Adaptin Bio's Other Accumulated Expenses stood at $15000.0 in 2022, then tumbled by 33.33% to $10000.0 in 2023, then surged by 347.5% to $44750.0 in 2024, then slumped by 71.9% to $12576.0 in 2025.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $12576.0, $44750.0, and $40500.0 for Q1 2025, Q3 2024, and Q2 2024 respectively.